Logiscreen

Integra Lifesciences Holdings Corp

$16.99
Market Cap 1.32B
ROE -47.6%
Gross Margin 55.4%
Debt/Equity 2.0
Current Ratio 3.4
Revenue QoQ 2.4%
EPS QoQ -0.8%
F-Score 5

About

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-2.76
vs median 33.61
P/B
1.31
vs median 2.16
ROE
-0.48
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics